The forecasted data indicates a steady increase in the share of corresponding/leading author roles in scientific publications in infectious diseases in China, rising marginally each year from 97.78% in 2024 to 97.89% in 2028. Given these values, the Compound Annual Growth Rate (CAGR) remains minimal but positive, suggesting slight but continued consolidation of China's influence in this field. With no historical 2023 data available in the dataset, precise year-on-year variation for the recent past cannot be calculated. However, the forecast displays consistent growth each year.
Future trends to monitor include the potential impact of international collaborations and the shifting focus on global health issues, which could influence the distribution of authorship roles. Additionally, any policy changes in research funding and publication standards could further shape the dynamics of scholarly contributions in this domain.
